Lord Abbett & CO. LLC purchased a new position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 178,518 shares of the biopharmaceutical company’s stock, valued at approximately $51,814,000. Lord Abbett & CO. LLC owned […]
Aadi Bioscience (NASDAQ:AADI – Get Rating) had its price target lowered by LADENBURG THALM/SH SH from $47.00 to $33.00 in a research report sent to investors on Thursday morning, The Fly reports. Separately, HC Wainwright reduced their price objective on shares of Aadi Bioscience from $48.00 to $45.00 and set a buy rating for the […]
A number of firms have modified their ratings and price targets on shares of CTI BioPharma (NASDAQ: CTIC) recently: 5/15/2023 – CTI BioPharma was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating. 5/11/2023 – CTI BioPharma was downgraded by analysts at JMP Securities from an “outperform” rating to a […]
Tiedemann Advisors LLC bought a new stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 1,492 shares of the biopharmaceutical company’s stock, valued at approximately $433,000. A number of other institutional […]
StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. AGLE has been the topic of several other research reports. Jonestrading restated a hold rating on shares of Aeglea BioTherapeutics in a research report on […]